A novel antimicrobial agent joins the battle against resistant bacteria

被引：44

作者：

Moellering, RC ^{[1
]}

机构：

[1] Harvard Univ, Sch Med, Boston, MA 02215 USA

来源：

ANNALS OF INTERNAL MEDICINE | 1999年 / 130卷 / 02期

关键词：

D O I：

10.7326/0003-4819-130-2-199901190-00012

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：155 / 157

页数：3

共 19 条

[1] DAPTOMYCIN DISRUPTS MEMBRANE-POTENTIAL IN GROWING STAPHYLOCOCCUS-AUREUS [J].

ALBORN, WE ;

ALLEN, NE ;

PRESTON, DA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (11) :2282-2287

[2] Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity [J].

Barbachyn, MR ;

Hutchinson, DK ;

Brickner, SJ ;

Cynamon, MH ;

Kilburn, JO ;

Klemens, SP ;

Glickman, SE ;

Grega, KC ;

Hendges, SK ;

Toops, DS ;

Ford, CW ;

Zurenko, GE .

JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (03) :680-685

[3]

BATTS DH, 1998, 2 EUR C CHEM HAMB GE

[4]

Brickner SJ, 1996, CURR PHARM DESIGN, V2, P175

[5] Medicine - Bacteria on the rampage [J].

Davies, J .

NATURE, 1996, 383 (6597) :219-220

[6] Oxazolidinones: New antibacterial agents [J].

Ford, CW ;

Hamel, JC ;

Stapert, D ;

Moerman, JK ;

Hutchinson, DK ;

Barbachyn, MR ;

Zurenko, GE .

TRENDS IN MICROBIOLOGY, 1997, 5 (05) :196-200

[7] Drug therapy - Antimicrobial-drug resistance [J].

Gold, HS ;

Moellering, RC .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (19) :1445-1453

[8] In vitro activity and spectrum of LY333328, a novel glycopeptide derivative [J].

Jones, RN ;

Barret, MS ;

Erwin, ME .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (02) :488-493

[9] Effect of quinupristin/dalfopristin on the outcome of vancomycin-resistant Enterococcus faecium bacteraemia: Comparison with a control cohort [J].

Linden, PK ;

Pasculle, AW ;

McDevitt, D ;

Kramer, DJ .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 :145-151

[10]

Moellering RC, 1998, CLIN INFECT DIS, V27, pS135

← 1 2 →